Owl Capital

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.

Lemonada Media is a podcast network focused on sharing authentic narratives that reflect the diverse facets of the human experience. Through its platform, the company produces first-person stories that resonate with listeners, fostering an engaged community. By presenting relatable content, Lemonada enables individuals to gain insights into various life experiences, promoting understanding and personal growth. The network aims to create a space where listeners not only feel connected to the stories shared but also find comfort and lessons applicable to their own lives.

Welcome Tech is a platform designed to support the 250 million global immigrant communities by connecting them with essential information, products, and services needed to thrive in a new environment. The company reaches over 9 million immigrants annually and has nearly 2 million active users. By utilizing a proprietary data and information engine, Welcome Tech offers tailored and relevant solutions across various sectors, including finance, education, healthcare, telecommunications, and government services. Founded by experts in immigration and technology, Welcome Tech is headquartered in Los Angeles, California, and aims to empower immigrant families to become informed and active participants in society.